U.S. Lateral Flow Assay Market Projected to Hit USD 5.39 Billion by 2034, Fueled by Point-of-Care Advancements and Rising Chronic Disease Incidence
The U.S. lateral flow assay market was valued at USD 2.97 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2025 to 2034. By the end of 2034, the market is anticipated to reach approximately USD 5.39 billion, fueled by advancements in point-of-care diagnostics, increasing prevalence of...
0 Commentarios 0 Acciones 7 Views 0 Vista previa